“showed a trend”

Although NEC + HD animals showed a trend toward reduced weight gain compared to NEC, this difference did not reach statistical significance ( p = 0.0567).

However, distant metastasis showed a trend to be higher in TEMs + patients ( p = 0.0568), while patient’s gender and age were not significantly associated with TEMs infiltration.

In particular, the group with the combination of CA and TDD treatments showed a trend to the highest levels of expression of these caspases, with levels very close to the significance for caspase 8 ( p = 0.0569) compared with the control group.

Importantly, we also found that patients who received EloPd immediately after daratumumab therapy showed a trend toward better OS ( P = 0.057), lacking statistical significance after adjustment for other confounders in the multivariable model, indicating that while the timing between therapies influences PFS, it does not have as strong an impact on long-term survival.

In addition, absolute CD4 + T cell counts showed a trend towards decreased naïve CD4 + T cells ( p = 0.057), which was not observed in naïve CD8 + T cells ( Figure 4 b).

Mean pacing threshold showed a trend for higher threshold at 1 year follow up (0.63 ± 0.26 V and 0.72 ± 0.26 V at 0.4 msec respectively, p = 0.057).

Telmisartan treatment showed a trend toward increasing the urine adenosine to urine creatinine ratio ( P = 0.057, Fig. 3 A ).

Though not statistically significant, HFD mice showed a trend of increased numbers of “lipid-laden-like” lesions ( Figure 3 A) after 6 months ( p = 0.057).

However, in a subsequent cohort study, we observed that COVID-19 patients with 25(OH)D levels <10 ng/mL showed a trend ( p =0.057) of longer length of hospital stay than those with 25(OH)D levels ≥10 ng/mL (95% confidence interval [CI]: 6.4-11.6 days versus 6.6-7.4 days) ( 8 ).

Moreover, the LC group showed a trend toward a decrease in leukocyte number (white blood cell; P = 0.057).

Amotivation showed a trend of increasing as the students got closer to graduation (p=0.057).

Male B6.Del16 +/ Bdh1-Tfrc mice showed a trend towards increased latency that did not reach significance (main effect of genotype, F 1, 28 = 3.922, p = 0.057), swam a greater distance (main effect of genotype, F 1, 28 = 4.621, p < 0.05), but had similar swim speed (main effect of genotype, F 1, 28 = 0.493, p > 0.05) to reach the hidden platform on day 5 compared with B6.WT littermates (Supplemental Fig. 5d–f ).

BCLC stage C showed a trend toward unfavorable prognosis versus stage B (HR 3.160, 95% CI 0.965-10.353; p=0.057).

Nonetheless, they showed a trend for a higher frequency of DRB1*01:01 (0.182 vs. 0.064, p = 0.057), DQA1*01:01 (0.227 vs. 0.108, p = 0.091) and DQB1*06:04 (0.091 vs. 0.015, p = 0.055).

Overall, the T cell repertoire of MDD patients showed a trend for higher Gini-TCR indices in CD4 + cells ( p = 0.057; Figure 5 A), indicating that the CD4 + TCR repertoire might be less evenly distributed in MDD.

The post-surgery group presented a significantly higher ratio (2.88 ± 15.74) in relation to the pre-surgery group (p < 0.05) and showed a trend towards a higher ratio when compared to the control (p = 0.057).

Specifically, NT children with a greater P50 response amplitude showed less tactile reactivity [partial correlation: r = − 0.35, p = 0.029, 95% CI [− 0.61 − 0.12]], whereas autistic children showed a trend towards the opposite pattern, with greater P50 response amplitude related to more tactile reactivity [partial correlation: r = 0.38, p = 0.057, 95% CI [− 0.19 0.75]] (Fig. 5 a).

However, in patients with ADC, the combination only showed a trend toward improved PFS (median PFS: 11.53 vs. 8.23 months, HR = 0.641, P = 0.057) and did not lead to a significant OS benefit (median OS: 21.87 vs. 30.50 months, HR = 1.043, P = 0.865).

Expression of WNT11 correlated significantly ( p = 0.014) and FZD8 showed a trend ( p = 0.057) with increased biochemical recurrence (Supplementary Fig. 8b ).

In the subsequent follitropin beta cycles, the number of retrieved oocytes showed a trend toward an increase compared with the preceding follitropin delta cycles (median 6.0 (IQR 3.0-9.0) vs. 5.0 (IQR 3.0-7.0); p = 0.057; n = 35), with improvement in 19 of 35 patients.

Levetiracetam showed a trend for the suppression of the P180 ( p = 0.057).

In the calcium surrounding CNs, nodules with lipid signal demonstrated a modest but statistically significant increase in arc (40.8 ± 13.1 to 43.9 ± 13.5°; Δ + 2.78 ± 1.18, P = 0.018), whereas depth showed a trend toward increase (0.65 ± 0.25 to 0.69 ± 0.26 mm; Δ + 0.04 ± 0.02, P = 0.057).

Glucose concentrations were lower in 2h‐HF‐2nd compared to CON (SNK; P =.023) and showed a trend to be lower compared to HF (SNK; P =.057); 2h‐HF‐1st showed a trend towards lower glucose concentrations compared to CON (SNK; P =.073).

Although overweight status (BMI >25.0) was not significantly different between the two IBS clusters, IBS1 [m(sd), 25.52 (5.68)] showed a trend ( t (27) = 1,99, p = .057) toward greater BMI compared to HC-like IBS [20.99 (6.51)], Hedge’s effect size g (Cohen’s d corrected for small sample sizes) = .74.

However, compared to the former, the latter group showed a trend toward lower hBD-2 levels (2152.5 ± 1251.6 vs. 1716.9 ± 1248.6 pg/mL, respectively; p = 0.057; Fig. 1 A).